Cover Image

Development and evaluation of a tetravalent botulinum vaccine

Botulinum neurotoxins (BoNTs) are the most toxic known proteins. Naturally occurring botulism in humans is caused by botulinum serotypes A, B, E, and F. Vaccination is an effective strategy to prevent botulism. In this study, a tetravalent botulinum vaccine (TBV) that can prevent serotypes A, B, E,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dan-Yang Shi (Author), Fu-Jia Liu (Author), Zhi-Ying Li (Author), Yun-Yun Mao (Author), Jian-Sheng Lu (Author), Rong Wang (Author), Xiao-Bin Pang (Author), Yun-Zhou Yu (Author), Zhi-Xin Yang (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E
by: Dan-Yang Shi, et al.
Published: (2020)

Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B
by: Dan-Yang Shi, et al.
Published: (2019)

A recombinant live attenuated tetravalent vaccine for the prevention of dengue
by: Bruno Guy, et al.
Published: (2017)

Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).
by: Claire Y-H Huang, et al.
Published: (2013)

Efficacy of tetravalent dengue vaccine: A systematic review and meta-analysis
by: Ashish Wasudeo Khobragade, et al.
Published: (2021)

Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines.
by: Philip K Russell, et al.
Published: (2016)

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
by: Sanford R Kimmel
Published: (2008)

Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination
by: Claire Vigne, et al.
Published: (2017)

Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City
by: Shibadas Biswal, et al.
Published: (2021)

Mirabegron in Overactive Bladder and Its Role in Exit Strategy After Botulinum Toxin Treatment in Children
by: Denise Jia Yun Tan, et al.
Published: (2022)

The effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules
by: Eduardo Lazcano-Ponce, et al.
Published: (2018)

Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates.
by: Fiona R Strouts, et al.
Published: (2016)

Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines
by: Paolo Bonanni, et al.
Published: (2020)

A case-control study to determine the effectiveness of a tetravalent dengue vaccine in the state of Paraná, Brazil
by: José Cássio de Moraes, et al.
Published: (2022)

The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017)

Can botulinum toxin injection alleviate the pain of bruxism? A Bayesian network analysis and a single-arm analysis
by: Ao-bo Zhang, et al.
Published: (2024)

Preparative separation and purification of deoxyschizandrin from Schisandrae Sphenantherae Fructus by high-speed counter-current chromatography
by: Xin-Ying Li, et al.
Published: (2013)

Treatment of non-odontogenic orofacial pain using botulinum toxin-A: a retrospective case series study
by: Sang-Yun Kim, et al.
Published: (2018)

Risperidone-induced neuroleptic malignant syndrome: a case report
by: Ling Deng, et al.
Published: (2022)

Single intravitreal administration of a tetravalent siRNA exhibits robust and efficient gene silencing in mouse and pig photoreceptors
by: Shun-Yun Cheng, et al.
Published: (2024)

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination.
by: Stephen S Whitehead, et al.
Published: (2017)

Temporospatial distribution of particles released by printer and influence of ventilation: an experimental study
by: Xin GUO, et al.
Published: (2022)

Design and evaluation of mRNA encoding recombinant neutralizing antibodies for botulinum neurotoxin type B intoxication prophylaxis
by: Gulisaina Qiaerxie, et al.
Published: (2024)

Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
by: Hong-Zhi Chen, et al.
Published: (2020)

Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity
by: Xinghua Pang, et al.
Published: (2023)

Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials.
by: Sophia Gailhardou, et al.
Published: (2016)

A Bispecific, Tetravalent Antibody Targeting Inflammatory and Pruritogenic Pathways in Atopic Dermatitis
by: Julia Tietz, et al.
Published: (2024)

Resveratrol overcomes TRAIL resistance in human colon cancer cells
by: Xiao-Bing Li, et al.
Published: (2015)

Usability and Effectiveness of eHealth and mHealth Interventions That Support Self-Management and Health Care Transition in Adolescents and Young Adults With Chronic Disease: Systematic Review
by: ZhiRu Li, et al.
Published: (2024)

Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003).
by: Laura J White, et al.
Published: (2021)

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial
by: Mark Turner, et al.
Published: (2020)

Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
by: Scott B. Halstead
Published: (2018)

Paeoniflorin exerts neuroprotective effects by modulating the M1/M2 subset polarization of microglia/macrophages in the hippocampal CA1 region of vascular dementia rats via cannabinoid receptor 2
by: Xian-Qin Luo, et al.
Published: (2018)

The mechanism of botulinum A on Raynaud syndrome
by: Zhou Y, et al.
Published: (2018)

Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype.
by: Stefan W Metz, et al.
Published: (2018)

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults
by: Susan B. Manoff, et al.
Published: (2019)

Global distribution of zoonotic digenetic trematodes: a scoping review
by: Yue Hu, et al.
Published: (2024)

Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Systematic Review of Case Reports
by: YunFan Dai, et al.
Published: (2020)

Botulinum Toxin
Published: (2018)

Botulinum toxin
by: Nigam P, et al.
Published: (2010)